Template:ABSTRACT PUBMED 10678179
From Proteopedia
(New page: <!-- This page is not licensed under the GNU FDL. This page contains an abstract from PubMed Central. The abstract on this page is material from PubMed Central contributed or licensed by i...) |
m (Protected "Template:ABSTRACT PUBMED 10678179" [edit=sysop:move=sysop]) |
Current revision
The action of 1 alpha, 25-dihydroxyvitamin D3 is mediated by its nuclear receptor (VDR), a ligand-dependent transcription regulator. We report the 1.8 A resolution crystal structure of the complex between a VDR ligand-binding domain (LBD) construct lacking the highly variable VDR-specific insertion domain and vitamin D. The construct exhibits the same binding affinity for vitamin D and transactivation ability as the wild-type protein, showing that the N-terminal part of the LBD is essential for its structural and functional integrity while the large insertion peptide is dispensable. The structure reveals the active conformation of the bound ligand and allows understanding of the different binding properties of some synthetic analogs.
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand., Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D, Mol Cell. 2000 Jan;5(1):173-9. PMID:10678179
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
